Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma: Two Single-arm, Prospective and Open-label Clinical Study

NCT05316467 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.

NCT NCT05316467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05316467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma: Two Single-arm, Prospective and Open-label Clinical Study
Lead sponsor
Xiaojun Chen
Phase
Phase 2/3
Overall status
Terminated
Start date
May 1, 2022
Completion date
February 28, 2026
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma, fertility issues, obese, overweight